Clinical TrialsSearch results
Number of results: 612
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- Evaluation of treatment response for immune checkpoint inhibitors in non-small cell lung cancer patients using [18F]F-AraG PET/CT
- Non-small cell lung cancer
- Nakamoto Yuji
- 2022-10-26
Recruiting
- A randomized controlled study of the usefulness of a novel device delivery system in the diagnosis of biliary stricture
- Biliary stricture
- Tomoaki Matsumori
- 2022-10-07
Recruiting
- A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination with Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment
- Relapsed or Refractory Multiple Myeloma
- Nishikawa Kazuko
- 2022-10-07
Completed
- Glucose management impact of "asken medical system" in patients with type 2 diabetes.
- Type 2 diabetes
- Kawashima Sachiko
- 2022-09-27
Other
- LOMCAD Trial
- Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL)
- Ohara Tomoyuki
- 2022-08-09
Recruiting
- Effects of Tea ingestion on COVID-19
- SARS-CoV2 Infection
- Mazda Osam
- 2022-07-26
Recruiting
- JCCG CNSGCT2021:
A Randomized Controlled Clinical Study in Patients with Central Nervous System Germ Cell Tumor
- Central Nervous System Germ Cell Tumor
- ARAKAWA Yoshiki
- 2022-07-22
Other
- Physician-initiated clinical trial in patients with 5-aminolevulinic acid-induced ATR-X syndrome.
- ATR-X syndrome
- Wada Takahito
- 2022-07-14
Recruiting
- Efficacy and safety of hemodilutional autologous blood transfusion for intermediate- to advanced- liver resection : An observational study
- All disease which would be required for hepatectomy
- Uchida Yoichiro
- 2022-07-14
Recruiting
- Ramucirumab and Erlotinib for NSCLC Patients with Brain Metastases
- non-small Cell Lung Cancer
- Takayama Koichi
- 2022-06-28